You searched for: pharmachemie (Engelska - Maltesiska)

pharmachemie b. v.
pharmachemie b. v.

pharmachemie bv swensweg 5
pharmachemie b.v. swensweg 5,

nederland pharmachemie b. v.
nederland pharmachemie b. v.

nederland pharmachemie bv telephone:
nederland pharmachemie bv telephone:

pharmachemie b.v. swensweg 5,
pharmachemie b.v. swensweg 5, postbus 552,

pharmachemie b.v. (pch) swensweg 5
pharmachemie b.v (pch) swensweg 5

manufacturer pharmachemie b.v. (pch) swensweg 5
manifattur pharmachemie b.v. (pch) swensweg 5

pharmachemie b. v (pch) swensweg 5 haarlem the netherlands
pharmachemie b. v (pch) swensweg 5 haarlem l- olanda

bleomycin „ pharmachemie“ 15000 i. e. - pulver zur herstellung einer injektionslösung
bleomycin „ pharmachemie “ 15000

overall summary of the scientific evaluation of bleomycin pharmachemie and associated names (see annex i)
sommarju Ġenerali tal- evalwazzjoni xjentifika ta ’ bleomycin pharmachemie u ismijiet assoĊjati (ara anness i)

questions and answers on the referral for bleomycin, powder for solution for injection, 15 u/ vial, from pharmachemie bv
mistoqsija u tweġiba dwar ir- referenza għal bleomycin, trab għal soluzzjoni għall- injezzjoni, 15 u/ kunjett, minn pharmachemie bv

the application for bleomycin pharmachemie was submitted as a generic application based on the marketing authorisation granted for the reference product in the netherlands on 18 november 1997.
l- applikazzjoni għal bleomycin pharmachemie ġiet sottomessa bħala applikazzjoni ġenerika bbażata fuq l - awtorizzazzjoni għat- tqegħid fis- suq mogħtija għall- prodott ta ’ referenza fl- olanda fit- 18 ta ’ novembru 1997.

therefore the chmp is of the opinion that bleomycin is still a valuable chemotherapeutic drug, and adopted the totality of the proposed indications, for bleomycin pharmachemie:
għaldaqstant, is- chmp huwa tal- opinjoni li l- bleomiċina xorta għadu mediċina kemjoterapewtika valida, u adotta l- indikazzjonijiet proposti kollha għal bleomycin pharmachemie:

pharmachemie bv submitted a marketing authorisation application for bleomycin powder for solution for injection 15 u/ vial in the decentralised procedure on 10 july 2007, the netherlands acting as the reference member state.
pharmachemie bv issottomettiet applikazzjoni għat- tqegħid fis- suq għal bleomycin trab għal soluzzjoni għall- injezzjoni 15 u/ kunjett fil- proċedura deċentralizzata fl- 10 ta ’ lulju 2007, bl- olanda taġixxi bħala l- istat membru ta ’ referenza.

krka, d.d., novo mesto, Šmarješka cesta 6, 8501 novo mesto, slovenia pharmachemie b.v., swensweg 5, 2031 ga haarlem, the netherlands
krka, d.d., novo mesto, Šmarješka cesta 6, 8501 novo mesto, is-slovenja pharmachemie b.v., swensweg 5, 2031 ga haarlem, l-olanda

krka, d.d., novo mesto, Šmarješka cesta 6, 8501 novo mesto, slovenia tad pharma gmbh, heinz-lohmann-straße 5, 27472 cuxhaven, germany pharmachemie b.v., swensweg 5, 2031 ga haarlem, the netherlands
krka, d.d., novo mesto, Šmarješka cesta 6, 8501 novo mesto, is-slovenja tad pharma gmbh, heinz-lohmann-straße 5, 27472 cuxhaven, il-Ġermanja pharmachemie b.v., swensweg 5, 2031 ga haarlem, l-olanda